Phase II Randomized Trial Comparing High-Dose IFN-a2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
Phase II Randomized Trial Comparing High-Dose IFN-a2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
复制标题
比较高剂量 IFN-a2b 与替莫唑胺加顺铂作为切除粘膜黑色素瘤全身辅助治疗的 II 期随机试验
作者：
Lu Si;Chuanliang Cui;Zhihong Chi;Xinan Sheng;Lili Mao;Siming Li;Yan Kong;Bixia Tang;Jun Guo
